The inhibitors of miR-224-5p, miR-339-5p, and miR-1198-5p improve auditory function by promoting the expression of neuritin in hearing loss mice
Pingping Meng, Zhiwei Zhong, Yin Song, Yu Wei, Jiawei Sun, Jingyi Chen, Yunhua Zhang, Jingling Zhu · 2026
Read The inhibitors of miR-224-5p, miR-339-5p, and miR-1198-5p improve auditory function by promoting the expression of neuritin in hearing loss mice by Pingping Meng, Zhiwei Zhong, Yin Song, Yu Wei, Jiawei Sun, Jingyi Chen, Yunhua Zhang, Jingling Zhu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0349821.txt.
Description
Pingping Meng and colleagues tested a gene-silencing treatment for the most common kind of hearing loss in mice. Their earlier work showed that a growth factor called neuritin, which supports nerve tissue, falls in the deafened inner ear, and replacing it protected hearing cells. Here they hunted for the tiny RNA switches, microRNAs, that turn neuritin down.
Sequencing the inner ear tissue nominated three microRNAs as the main culprits. Blocking each of them in living mice raised neuritin levels and improved hearing function. With no effective drug yet for sensorineural hearing loss, a treatment that works by releasing a natural protective factor, rather than adding a foreign one, is an appealing direction worth developing.
Catalog record
| CREATOR | Pingping Meng, Zhiwei Zhong, Yin Song, Yu Wei, Jiawei Sun, Jingyi Chen, Yunhua Zhang, Jingling Zhu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43843 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |